Category: Pharma Industry

Biocon Announces New NDC for its Lantus Biosimilar

October 26, 2023 Tom Mirga, Editor at Large Views

Biocon has added a new national drug code for its insulin biosimilar, the drugmaker recently notified 340B providers.

Indian biopharmaceutical manufacturer Biocon Biologics has notified 340B covered entities about a new national drug code (NDC) for insulin glargine-yfgn, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genentech Asks Hospitals to Check 340B Split-Billing Software Settings

October 24, 2023 Tom Mirga, Editor at Large Views

Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.

Drug manufacturer Genentech has asked health systems and hospitals about possible 340B program compliance violations involving split-billing software settings. Staff [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Teva Adds Drug to Hospital Contract Pharmacy Restriction Policy

October 24, 2023 Rich Daly, Editor in Chief Views

Drugmaker Teva recently added its medication Austedo to its list of drugs under 340B contract pharmacy restrictions for hospitals.

Drug manufacturer Teva this week added a drug to the hospital contract pharmacy restrictions it first implemented in June. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

October 19, 2023 Rich Daly, Editor in Chief Views

HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.

A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Five More Providers Owe Drugmakers 340B Repayment: Audits

October 19, 2023 Rich Daly, Editor in Chief Views

HRSA confirmed it will end a pandemic-era waiver program that allowed 340B drug use in certain offsite hospital locations.

A total of 16 covered entities (CEs) owe repayment to drugmakers, five more than reported a month ago, according to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Most 340B DSH Hospitals Provide Below-Average Charity Care, Says Analysis Backed by Critics

October 19, 2023 Rich Daly, Editor in Chief Views

Bob Dold, a spokesperson for AIR340B, said the 340B program "has not translated into a stronger safety-net” after a drug industry backed analysis found 340B DSH hospitals provide below-average charity care.

The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price

October 19, 2023 Tom Mirga, Editor at Large Views

An Avalere study suggested 340B duplicate discounts could increase as a result of Medicare drug price negotiations.

Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Eisai’s New 340B Contract Pharmacy Restrictions to Exclude Arkansas and Louisiana

October 17, 2023 William Newton, Associate Editor/Senior Writer Views

Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.

Japanese pharmaceutical manufacturer Eisai will not limit hospital 340B contract pharmacy use in Arkansas and Louisiana after its new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New BMS Contract Pharmacy Policy May Target Hospital Self-Distribution, Say Attorneys

October 17, 2023 Rich Daly, Editor in Chief Views

William von Oehsen, principal at the law firm Powers, said the SUSTAIN ACT is "not going to live or die based on the user fee."

Drugmaker Bristol Myers Squibb added new language to its latest 340B contract pharmacy policy notice, which appears to target hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk Files Suit to Block $100,000 Arkansas Fine for 340B Contract Pharmacy Violations

October 13, 2023 William Newton, Associate Editor/Senior Writer Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

Danish drug giant Novo Nordisk filed suit Thursday to stop a proposed $100,000 fine from Arkansas over alleged violations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

Biocon Announces New NDC for its Lantus Biosimilar

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Genentech Asks Hospitals to Check 340B Split-Billing Software Settings

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Teva Adds Drug to Hospital Contract Pharmacy Restriction Policy

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Five More Providers Owe Drugmakers 340B Repayment: Audits

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Most 340B DSH Hospitals Provide Below-Average Charity Care, Says Analysis Backed by Critics

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Eisai’s New 340B Contract Pharmacy Restrictions to Exclude Arkansas and Louisiana

Please Login or Become a Paid Subscriber to View this Content

If you are already a

New BMS Contract Pharmacy Policy May Target Hospital Self-Distribution, Say Attorneys

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Novo Nordisk Files Suit to Block $100,000 Arkansas Fine for 340B Contract Pharmacy Violations

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live